We are concerned that the coronavirus could prove to be a headwind to short-term economic growth. At the moment, it is not clear whether the crisis will last a few months or longer.
The accepted wisdom is that a vaccine is 16 to 18 months away but we could see the first batches of a Covid-19 vaccine available for emergency use authorisation in early 2021. Abbott Laboratories' point of care test can detect Covid-19 in just five minutes. It is too early to judge the likely economic impact of the coronavirus but, as the disease seems likely to persist into the summer, it will be damaging. The global stocks that have been hardest hit in the sell-off are those with long, complex and thin supply chains, and those with high levels of indebtedness. Church House: Why t...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes